Equine p-tau413 antibody and antigen (recombinant protein)

Diagnostic anti-Equine p-tau413 antibodies pairs and antigen for animal health (animal Equine/Horse Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-p-tau413-Ag01Equine p-tau413$3090.00
GMP-EQU-p-tau413-Ab01Anti-Equine p-tau413 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-p-tau413-Ab02Anti-Equine p-tau413 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-p-tau413-Ab03Anti-Equine p-tau413 human monoclonal antibody (mAb)$3090.00
GMP-EQU-p-tau413-Ab04Anti-Equine p-tau413 human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-p-tau413-Ag01
Product NameEquine p-tau413
Target/BiomarkerEquine p-tau413
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine p-tau413 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau413 level test of animal Equine/Horse with Alzheimer Disease(AD).
TagHis
Reconized/Reactive SpecicsEquine p-tau413
Product descriptionRecombinant Equine p-tau413 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-p-tau413-Ab01,GMP-EQU-p-tau413-Ab02
Target/BiomarkerEquine p-tau413
Product NameAnti-Equine p-tau413 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine p-tau413 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine p-tau413 antibodies in Equine p-tau413 level test of animal Equine/Horse with Alzheimer Disease(AD).
Product descriptionAnti-Equine p-tau413 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine p-tau413 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-p-tau413-Ab03,GMP-EQU-p-tau413-Ab04
Target/BiomarkerEquine p-tau413
Product NameAnti-Equine p-tau413 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine p-tau413 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine p-tau413 antibodies in Equine p-tau413 level test of animal Equine/Horse with Alzheimer Disease(AD).
Product descriptionAnti-Equine p-tau413 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine p-tau413 represents a specific subset of tau proteins intricately involved in the neurological landscape of horses. These phosphorylated tau variants are primarily localized within the central nervous system (CNS) of equines, where they play a vital role in maintaining the structural stability of neuronal microtubules.

    Structurally, tau proteins like p-tau413 belong to the tau protein family, sharing genetic and functional homology with their counterparts in other species, including humans. Under normal circumstances, tau proteins bind to microtubules and aid in their assembly, ensuring proper neuronal function, axonal transport, and synaptic communication.

    However, in the context of neurodegenerative disorders observed in horses, tau proteins like p-tau413 undergo abnormal phosphorylation. This post-translational modification results in tau proteins adopting atypical conformations, rendering them prone to aggregation. The aggregation of tau proteins culminates in the formation of neurofibrillary tangles within neurons. These tangles disrupt axonal transport, impair synaptic function, and eventually result in neuronal dysfunction and death. The presence of elevated levels of p-tau413 is indicative of these pathological tau modifications and the potential development of neurodegenerative diseases in horses.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.